Our mission is to bring innovative technologies to practical diagnosis of diseases related with tumor processes
Initially, MiWendo solutions will develop and launch a novel endoscopy accessory medical device based on microwave technology targeting colorectal cancer early detection, with the final aim of reducing its incidence and mortality.
- European Commission EIC Accelerator (Grant Agreement No. 960251)
- Doctorados industriales (DIN2019-010857)
- EIT Health Headstart (ID 2020-HS-0067)
- Instituto de Salud Carlos III DTS (DTS17/00090)
- Caixaimpulse (CI16-00058)
- IC Producte (2016 PROD 00048)
- IC Llavor (2014 LLAV 00016)
- MiWEndo Solutions has received funding to carry out the project CPP2021/008536 – Disruptive technologies for early detection of colorectal cancer – TEDCRC” by MIC/AEI/10.13039/501100011033 and by European Union Next GenerationEU/PRTR
- This project has received funding from the Eurostars-3 joint program with co-funding from CDTI and the European Union’s Horizon Europe Framework Program for Research and Innovation.
Patents
- EP 3 195 786 A1
- E 16152033 ES
- E 16152033 IT
- E 16152033 FR
- E 16152033 DE
- E 16152033 GB
- JP6815405 (B2)
Publications
- Medical Physics
- Dielectric properties of colon polyps, cancer, and normal mucosa: Ex vivo measurements from 0.5 to 20 GHz
- IEEE Trans. Antennas Propagation
- Microwave-Based Colonoscopy: Preclinical Evaluation in an Ex Vivo Human Colon Model
- Automatic Polyp Detection Using Microwave Endoscopy for Colorectal Cancer Prevention and Early Detection: Phantom Validation
- Preclinical Evaluation of a Microwave-Based Accessory Device for Colonoscopy in an In Vivo Porcine Model with Colorectal Polyps
Awards
- I Campus Clínic Innovation Awards
- DWF-RCD Award
- Premio Josemi Azkoitia
- Healthy Longevity Global Grand Challenge Award
- Premi Dona TIC
- Premi Societat Catalana de Biologia Startup
- The Spinoff Prize, a Nature Research Award
- Fundación MAPFRE Social Innovation Awards
- Brightlands Award
- Premi Consell Social UPF
- Premio RAI
- Premio Pyme del año
- Premi Salvà i Campillo
- Premio Duran Farell
Our Quality Policy
- Company operates under a quality management system according to the standards ISO 13485 on medical devices.
- MiWEndo has successfully passed a pilot clinical investigation of 15 patients, and we are now initiating a pivotal study involving 50 patients.
- Regulatory market release for EU and US market is in process.
- Initially, MiWendo Solutions will develop and launch a novel endoscopy accessory medical device based on microwave technology targeting colorectal cancer early detection, with the final aim of reducing its incidence and mortality.